Cargando…
In Vitro Assays to Identify Metabolism-Disrupting Chemicals with Diabetogenic Activity in a Human Pancreatic β-Cell Model
There is a need to develop identification tests for Metabolism Disrupting Chemicals (MDCs) with diabetogenic activity. Here we used the human EndoC-βH1 β-cell line, the rat β-cell line INS-1E and dispersed mouse islet cells to assess the effects of endocrine disruptors on cell viability and glucose-...
Autores principales: | Dos Santos, Reinaldo Sousa, Medina-Gali, Regla María, Babiloni-Chust, Ignacio, Marroqui, Laura, Nadal, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102687/ https://www.ncbi.nlm.nih.gov/pubmed/35563431 http://dx.doi.org/10.3390/ijms23095040 |
Ejemplares similares
-
Screening of Metabolism-Disrupting Chemicals on Pancreatic α-Cells Using In Vitro Methods
por: Dos Santos, Reinaldo Sousa, et al.
Publicado: (2022) -
BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis
por: Perez-Serna, Atenea A., et al.
Publicado: (2023) -
Pancreatic alpha-cell mass in the early-onset and advanced stage of a mouse model of experimental autoimmune diabetes
por: Bru-Tari, Eva, et al.
Publicado: (2019) -
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults
por: Dos Santos, Reinaldo S., et al.
Publicado: (2023) -
Diabetogene Umweltfaktoren
por: Wabnitz, Katharina, et al.
Publicado: (2022)